Description
INCORPORATE FAR CLAUSE 52.222-90 IMPLEMENTING EO 14398 DEI DISCRIMINATION
Base award description: UNIT RADIOPHARMACEUTICALS
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-08-30+$0= $0
- Mod P000012025-08-01+$0= $0
- Mod P000032026-07-13+$0= $0
- Mod P000022026-07-28+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-08-30 | +$0 | $0 | UNIT RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2025-08-01 | +$0 | $0 | UNIT RADIOPHARMACEUTICALS |
| Mod P00003· EXERCISE AN OPTION | 2026-07-13 | +$0 | $0 | EXERCISE OPTION YEAR |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-07-28 | +$0 | $0 | INCORPORATE FAR CLAUSE 52.222-90 IMPLEMENTING EO 14398 DEI DISCRIMINATION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HNVPCZHVJP11)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0352 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,394,313 | FY2026 |
| 36C25525N0411 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,353,702 | FY2025 |
| 36C25524N0399 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $912,444 | FY2024 |
| 36C25522N0225 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,030,528 | FY2022 |
| 36C25521F0049 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $457,538 | FY2021 |
| 36C25520N0159 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $402,452 | FY2020 |
Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526N0376 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $233,435 | FY2026 |
| 36C25526N0394 | NOVARTIS PHARMACEUTICALS CORPORATION | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $891,651 | FY2026 |
| 36C25526N0392 | SOFIE CO. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $357,066 | FY2026 |
| 36C25526N0361 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $228,679 | FY2026 |
| 36C25526D0057 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36C25524D0033_3600 · retrieved 2026-09-26.